MAPT and Alzheimer disease: Using a different mouse model of AD involving P301L human tau transgenic pR5 mouse, the efficacy of an anti-tau antibody delivered by a scanning ultrasound combined with MBs (SUS/MB, sonication to the entire forebrain, 1 MHz, 0.7 MPa, 10% duty cycle at 1 Hz) was investigated 11.